Detalles de la búsqueda
1.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126318
2.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572549
3.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050405
4.
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Haematologica
; 108(1): 22-33, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35545919
5.
Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy.
J Thromb Thrombolysis
; 46(2): 174-179, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29737462
6.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966980
7.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533127
8.
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience.
Cancers (Basel)
; 15(13)2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444567
9.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36923264
10.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol
; 16(1): 32, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005697
11.
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.
EClinicalMedicine
; 58: 101939, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37041967
12.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Int J Antimicrob Agents
; 62(4): 106952, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582478
13.
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Int J Infect Dis
; 137: 98-110, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37863310
14.
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study.
J Fungi (Basel)
; 8(6)2022 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736066
15.
Long-Term Follow-Up of Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine: A Real-World Study of the Apulian Hematological Network.
Cancers (Basel)
; 14(3)2022 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35159092
16.
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.
Cancers (Basel)
; 14(22)2022 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428621
17.
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.
Hemasphere
; 6(11): e789, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36310756
18.
Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series.
Anticancer Res
; 35(1): 461-6, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25550588
19.
Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP).
Leuk Res
; 2015 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26364798
20.
Non-treatment-related chronic myeloid leukemia as a second malignancy.
Leuk Res
; 28(2): 115-9, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14654074